Download the
latest issue of
Scientific American Worldview »
Scorecard
Scorecard
Scorecard Data Points
Country Spotlights
Honduras
Hungary
Ireland
Italy
Japan
Saudi Arabia
Switzerland
Uganda
United States
Vietnam
Perspectives
Profiles
Special Report: the BRICs
Special Report: the BRICs
BRICs Perspectives
About Us
Editors' Letter
Contact Us
Masthead
Our Sponsors
Country Spotlights
A-MAIZING OPPORTUNITIES
Honduras leads the way for genetically modified crops in Central America
by Christine Bahls
Persistence Paying Off
From a delegation of one to a biotechnology association promised high priority in Hungary
by Jennifer Mackenzie
Really Flowing
In Ireland, Cellix focuses microscopic technology on moving cells
by Meredith Small
Biotech, Italian-style
In Italy, many international players sit at the table
by Brendan Borell
Trying to Transform
The Japanese government hopes a new center for biotechnology will revitalize Okinawa’s sluggish economy
by Isaac Stone Fish
A Seed Fund Sprouts in the Desert
Billions of dollars drive discoveries in Saudi Arabia
by Michael Szpir
Bio Logic
A new ‘account’ keeps biologics data safe in Switzerland
by Bill Cannon
The Bananas Bellwether
Bunches of field trials for genetically modified crops make Uganda a go-to place for agricultural science
by Karyn Hede
Computing New Compounds
Advanced computers help researchers create new drugs at Argonne in the U.S.
by Dan Ferber
Biofueling Up
Vietnamese farmers and companies look to make gas, ethanol and diesel from renewable sources
by Elie Dolgin
2: Intensity
Measuring a country's biotech "blood pressure" demands multiple approaches
3: Enterprise Support
Biotechnology thrives only when a country maintains a broad collection of business resources
Worldview Scorecard
MORE
Honduras
Saudi Arabia
Hungary
Switzerland
Ireland
Uganda
Italy
U.S.
Japan
Vietnam
Country Spotlights
MORE
More Angles for an Expanding Story
Eggplant Surprise
The Puzzle of India's First Transgenic Vegetable
Perspectives
MORE
Advertisement
Charting Her Own Course
An Indian CEO embraces research alongside the development of generics and biosimilars
Building the Critical Mass
A Brazilian CEO turned venture capitalist makes multiple contributions to the biotech field
Profiles
MORE